Found 54 clinical trials
A Randomized, Double-Blind, Double-Dummy, Active-Controlled Study Comparing the Efficacy, Safety and Tolerability of ABBV-951 to Oral Carbidopa/Levodopa in Advanced Parkinson's Disease Patients
The purpose of this study is to find out how well ABBV-951 works to control Parkinson's disease symptoms compared to oral Carbidopa (CD)/Levodopa (LD). The study is also
- 102 views
- 23 Nov, 2020
- 1 location
Neurovascular effects of dopamine replacement therapy in Parkinson's disease
The goal of this research study is to understand the evolution of levodopa-induced dyskinesias (LID), a refractory and disabling side effect of the gold standard treatment of Parkinson's disease
- 97 views
- 13 Aug, 2020
- 1 location
A Study to Evaluate the Safety and Efficacy of IPX203 in Parkinson's Disease Patients With Motor Fluctuations
To evaluate the safety and efficacy of IPX203 (carbidopa and levodopa) extended-release capsules (IPX203 ER CD-LD) in comparison to immediate release (IR) CD-LD in the
- 54 views
- 23 Nov, 2020
- 1 location
Parkinson's Disease Study at Wake Research
and Drug Administration [FDA] in the USA as an example). ABBV-951 is a formulation of carbidopa and levodopa, which are medications commonly used to treat symptoms in PD.
- 75 views
- 23 Nov, 2020
- 1 location
A Phase III, Multicenter, Randomized, Double-Blind, Double-Dummy, Active-Controlled Study Comparing the Efficacy and Safety of Gastric Retentive, Controlled Release Accordion Pill™ Carbidopa/Levodopa (AP-CD/LD) to Immediate Release CD/LD in Fluctuating Parkinson’s Disease Patients
A Phase III, Multicenter, Randomized, Double-Blind, Double-Dummy, Active-Controlled Study Comparing the Efficacy and Safety of Gastric Retentive, Controlled Release Accordion Pill™ Carbidopa/Levodopa
- 342 views
- 08 Nov, 2020
- 1 location
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label Phase to Determine the Efficacy and Safety of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off" (TOZ-PD)
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label Phase to Determine the Efficacy and Safety of Tozadenant as Adjunctive Therapy in Levodopa-Treated
- 222 views
- 23 Nov, 2020
- 1 location
An Open-Label Trial Of Oral Selegiline 5 Or 10 Mg And Tadalafil 2.5 Mg Co-Administration To Male Patients With Parkinson's Disease And Moderate Erectile Dysfunction.
An Open-Label Trial Of Oral Selegiline 5 Or 10 Mg And Tadalafil 2.5 Mg Co-Administration To Male Patients With Parkinson's Disease And Moderate Erectile Dysfunction.
- 886 views
- 08 Nov, 2020
- 2 locations
Open Label Parkinson's clinical research study
Open Label Parkinson's clinical research study
- 568 views
- 25 Mar, 2021
- 1 location
Dopaminergic Enhancement of Learning and Memory in Healthy Adults and Patients With Dementia/Mild Cognitive Impairment
This study aims to determine whether levodopa is effective in boosting learning and memory in healthy subjects and patients with dementia or Mild Cognitive Impairment. We also examine in
- 36 views
- 07 Nov, 2020
- 1 location